SCHEMBL3913407

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL12794421	0.90	MET (0.48)	METAXLSRCTGFBR1MST1R
	SCHEMBL3984028	0.87	MET (0.55)	METAXLSRCFGFR2MST1R
	SCHEMBL3989007	0.84	MET (0.57)	METAXLSRCMST1RKDR
	SCHEMBL3986569	0.84	MET (0.61)	METAXLMST1RKDRHGF
	SCHEMBL3985143	0.83	SRC (0.57)	METAXLSRCTGFBR1MST1R
	SCHEMBL3982270	0.82	MET (0.54)	METAXLSRCMST1RKDR
	SCHEMBL15338419	0.82	SRC (0.70)	METAXLSRCTGFBR1FGFR2
	SCHEMBL3912096	0.79	MET (0.53)	METSRCMST1RKDRAURKA
	SCHEMBL13511893	0.78	MET (0.58)	METAXLMST1RKDRHGF
	SCHEMBL371800	0.78	MET (0.59)	METAXLKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.